This retail stock should continue to climb higher.
Read MoreThese 2 stocks could get a big boost from a possible infrastructure proposal.
Read MoreThis expert says investors are “playing with fire” in what he calls the fourth “‘Real McCoys’ bubble” of his investing career.
Read MoreAs chip stocks climb higher, these 3 stocks in the sector are buys now.
Read MoreThese 9 stocks have exploded higher since the market bottom.
Read MoreTrade Setup Buy Target $14.27 Sell Target $15.19 XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases.
Read MorePlus, former FDA Commissioner Dr. Scott Gottlieb said states seeing surges of new coronavirus cases are “on the cusp of losing control” of their outbreaks, Wirecard shares are down after the German payments company said auditors couldn’t confirm the existence of $2.1 billion of cash on its balance sheet, and Spotify shares are up after it inks another big podcast deal.
Read MoreNo matter what current market conditions are at any given time, the point of value-oriented investing is to find stocks that offer attractive long-term upside. For my approach, that means using a combination of valuation, fundamental strength, and technical analysis to filter through the thousands of stocks that are available. With investors seemingly anxious to […]
Read More